874 filings
Page 2 of 44
8-K
nb8psdppamyz
27 Feb 24
Other Events
4:14pm
8-K
ny4mos
21 Feb 24
Other Events
7:01am
8-K
ipv9yvyh
15 Feb 24
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
5:15pm
424B1
5c2dsehrht
14 Feb 24
Prospectus with pricing info
9:21pm
EFFECT
sbyuz 6hu9g
14 Feb 24
Notice of effectiveness
12:15am
CORRESP
4z8dfy0a89 ceksv0
9 Feb 24
Correspondence with SEC
12:00am
8-K
gm6dd2rgrotcnqucg
7 Feb 24
Results of Operations and Financial Condition
6:04am
8-K
3k5xayrrs5m uwc5i9a
29 Jan 24
Biolase Reports Unaudited Revenue Growth for Full Year 2023 and Provides
5:01pm
S-8
e87vzve51h0piz1ioh
24 Jan 24
Registration of securities for employees
5:21pm
UPLOAD
sd071s7b n66r
24 Jan 24
Letter from SEC
12:00am
8-K
ox6q6 jula
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
D
zi3pe v72m0rf3rz
20 Dec 23
$2.73 mm in equity / options / securities to be acquired, sold $2.73 mm, 1 investor
2:13pm
8-K
4m7z99k lj
8 Dec 23
Biolase, Inc. Announces Pricing of $1.4 Million Registered Direct
9:25am
424B5
s98sy1385ov6lrl0
8 Dec 23
Prospectus supplement for primary offering
9:23am
8-K
u6kictda6r
17 Nov 23
Entry into a Material Definitive Agreement
4:17pm